Skyepharma Balance Sheet - Annual (OTCMKTS:SKYEY)

Add to My Stocks
$6.28 $0.02 (0.32%) SKYEY stock closing price Jun 24, 2016 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Skyepharma stock analysis. Financial strength can be guaged by performing Skyepharma stock analysis and by analyzing the balance sheet. Good annual results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. The Skyepharma balance sheet for 2015 shows total assets of $157.78M. The company has a asset turnover ratio of . Also see: Skyepharma revenue and Skyepharma operating cash flow for the same year.

View latest 10 year balance sheet data to check Skyepharma financial performance.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec20152014201320122011201020092008
Marketable Securities--------
Raw Materials9.93M-------
Work In Progress2.44M-------
Finished Goods2.44M-------
Notes Receivable--------
Other Current Assets-3.29M3.12M-18.93M---
Total Current Assets
Property Plant & Equipment--------
Accumulated Depreciation--------
Net Property Plant & Equipment
Investment & Advances--------
Other Non-Current Assets-6.42M-----7.23M
Deferred Charges2.9M-------
Deposits & Other Assets6.88M----6.49M--
Total Assets
Notes Payable-9.22M15.33M16M31.44M42.21M20.98M23.74M
Accounts Payable45.86M48.28M35.05M36.29M11.07M25.2M21.45M48.23M
Current Portion Long-Term Debt4.58M-------
Current Portion Capital Leases--------
Accrued Expenses--------
Income Taxes Payable6.42M-------
Other Current Liabilities1.22M6.75M2.03M2.06M12.67M2.16M1.56M2.96M
Total Current Liabilities
Deferred Taxes/Income5.96M11.37M16.58M18.86M18.29M16.7M16.91M23M
Convertible Debt----96.42M91.69M91.6M116.3M
Long-Term Debt7.33M19.44M142.24M137.9M55.35M62.93M97.39M140.98M
Non-Current Capital Leases--------
Other Long-Term Liabilities10.09M10.05M6.57M8.4M12.19M12.52M5.79M6.86M
Total Liabilities
Minority Interest--------
Preferred Stock--------
Common Stock Net274.29M295.66M188.87M191.32M158.03M152.31M154.24M179.37M
Capital Surplus622.58M671.1M565.98M573.33M626.03M603.36M611.01M718.25M
Retained Earnings-779.3M-894.58M-830.59M-843.27M-888.19M-853.86M-873.92M-1.02B
Treasury Stock--------
Other Liabilities-41.28M-27.35M-25.34M-25.99M-26.95M-25.35M-15.97M-46.56M
Shareholders Equity76.29M44.82M-101.08M-104.61M-131.07M-123.54M-124.64M-166.57M
Total Liabilities & Shareholders Equity157.78M149.97M116.73M114.91M106.37M129.88M131.06M195.51M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Most investors just check the Skyepharma stock price, and Skyepharma historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Skyepharma PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: An asset is a resource that a corporation like Skyepharma owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for SKYEY stock as of 2015 is $157.78M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. SKYEY stock had total liabilities of $81.49M for the year 2015.